Profound Medical Corp. (PROF)
6.43
-0.10
(-1.53%)
USD |
NASDAQ |
Apr 02, 16:00
6.40
-0.03
(-0.47%)
After-Hours: 20:00
Profound Medical EPS Diluted (Quarterly) : -0.2661 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.052 |
| Quest Diagnostics, Inc. | 2.188 |
| CytoSorbents Corp. | -0.0875 |
| Cardiac Biotech Solutions, Inc. | -0.0035 |
| Odyssey Health, Inc. | -0.0334 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.175M |
| Revenue (Quarterly) | 5.977M |
| Total Expenses (Quarterly) | 14.15M |
| Enterprise Value | 178.36M |
| Gross Profit Margin (Quarterly) | 66.77% |
| Profit Margin (Quarterly) | -136.8% |
| Earnings Yield | -21.93% |
| Normalized Earnings Yield | -21.93 |